GORTEC 2007-01

PDF Publication

Multicenter, randomized, phase III trial evaluating the benefit of concomitant chemotherapy in patients receiving radiotherapy - Erbitux for locally advanced carcinoma of the upper aerodigestive tract <= N2a.
Coordinator : Prof. BOURHIS
Start date : 2008
Number of patients    406

Access the Clinical Trials link

Access detailed information on the trial in the private section

 

GORTEC 2007-02

PDF Publication

Randomized, multicenter Phase III study, comparing an induction chemotherapy with TPF followed by radiotherapy and concurrent Erbitux® versus chemoradiotherapy for patients with inoperable locally advanced squamous cell carcinoma of the upper aerodigestive tract >=N2b
Coordinator : Dr GEOFFROIS
Start date : 2009
Number of patients    360

Access the Clinical Trials link

Access detailed information on the trial in the private section

 

GORTEC 99-02

GORTEC 99-02 phase III randomized trial, conventional radiotherapy + concomitant chemoradiotherapy versus accelerated radiotherapy + concomitant chemotherapy versus very accelerated radiotherapy in upper aerodigestive tract carcinoma
Coordinator : Prof. BOURHIS
Start date : 2000
Number of patients : 840

Access detailed information on the trial in the private section

 

TREMPLIN

Randomized phase II study comparing TPF followed by RT-Erbitux versus TPF followed by RT-cisplatin for larynx preservation
Coordinator : Prof. LEFEBVRE
Start date : 2004
Number of patients : 153

Access detailed information on the trial in the private section

 

GORTEC 94-01

Concomitant radiochemotherapy vs radiotherapy alone in the treatment of locally advanced squamous cell carcinoma of the upper aerodigestive tract.
Coordinator : Prof. CALAIS
Start date : 1994
Number of patients : 226

Access detailed information on the trial in the private section

 

GORTEC 94-02

Very accelerated radiochemotherapy vs conventional radiotherapy in the treatment of locally advanced squamous cell carcinoma of the upper aerodigestive tract.
Coordinator : Prof. BOURHIS
Start date : 1994
Number of patients : 268

Access detailed information on the trial in the private section

 

GORTEC 98-01

Phase II study evaluating the combination of cisplatin, 5FU and concomitant radiotherapy in patients having undergone surgery at high risk of recurrence.
Coordinator : Dr GEOFFROIS
Start date : 2000 
Number of patients : 61

Access detailed information on the trial in the private section

 

GORTEC 2000-02

Larynx preservation - Phase II randomized trial comparing TPF versus PF in larynx preservation
Coordinator : Prof. CALAIS
Start date : 2000
Number of patients : 215

Access detailed information on the trial in the private section

 

GORTEC/GETTEC JANORL1

Phase III randomized trial evaluating re-irradiation and concomitant chemotherapy following salvage surgery.
Coordinator : Dr JANOT
Start date : 2001
Number of patients : 125

Access detailed information on the trial in the private section

 

GORTEC 2004-02

Phase I/II, two-center, dose escalation study of oral Etoposide + conventional radiotherapy in carcinoma of the upper aerodigestive tract.
Coordinator Prof. BOURHIS / Dr Tao / Dr Bardet
Start date : 2005
Number of patients : 16

Access detailed information on the trial in the private section

 


GORTEC 2007

Title Phase I dose escalation study by IMRT in stages I and II
Coordinator : Prof. GREGOIRE / Prof. MAINGON
Start date 2006

Access detailed information on the trial in the private section

 


GORTEC 2006-01

Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck
Coordinator : DR MACHIELS
Start date : 2006 
Number of patients : 38

Access detailed information on the trial in the private section

 


GORTEC 2008-02

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck : GORTEC 2008-02.
Coordinator : DR MACHIELS / Prof. GUIGAY
Start date : 2008

Access detailed information on the trial in the private section

 

CIRCUTEC

Assessment of circulating tumor cells as an early predictive marker of response to treatment.
Coordinator : Dr CUPISSOL - Dr PANABIERES - Dr COSTES - Dr GABREL
Start date : 2013
Number of patients    110

Access the Clinical Trials link

Access detailed information on the trial in the private section

 

GORTEC 2009-01 RGTA

Multicenter, randomized trial evaluating the effect of OTD70DERM® on radiation-induced dermatitis caused by the combination of radiotherapy-Erbitux®
Coordinator : Dr TAO / Prof. BOURHIS 
Start date : 2010
Number of patients    70

Access the Clinical Trials link

Access detailed information on the trial in the private section

 

GORTEC 2008-03 TPEx

Phase II study evaluating the combination of cetuximab, docetaxel and cisplatin as first-line treatment of metastatic or recurrent squamous cell carcinoma of the head and neck.
Coordinator : Prof. GUIGAY
Start date : 2009
Number of patients : 54

Link to clinical trials

Access detailed information on the trial in the private section

 

GORTEC NPC 2006

Randomized, multicenter, phase III trial comparing induction chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) followed by concurrent chemotherapy-radiotherapy to concurrent chemotherapy-radiotherapy alone, in nasopharyngeal cancers staged as T2b, T3, T4 and/or with lymph node involvement (>N1)
Coordinator : Prof. FRIKHA - Prof. DAOUD - Prof. BOURHIS 
Start date : 2008
Number of patients    83

Access the Clinical Trials link

Access detailed information on the trial in the private section

 

GORTEC 96-01 (VADN3)

Concurrent accelerated radiotherapy and chemotherapy vs accelerated radiotherapy alone in inoperable N3 locally advanced squamous cell carcinoma of the upper aerodigestive tract. Phase II randomized study
Coordinator : Prof. BOURHIS
Start date : 1996
Number of patients : 109

Access detailed information on the trial in the private section

 


GORTEC 98-02

Phase III randomized trial - Re-irradiation and 5FU-Hydrea versus methotrexate in the palliative treatment of recurrent upper aerodigestive tract carcinoma in an irradiated area
Coordinator : Dr TORTOCHAUX
Start date : 1998    
Number of patients : 60

Access detailed information on the trial in the private section

 

GORTEC 2000-01

Functional update - Phase III randomized trial comparing TPF versus PF in larynx preservation
Coordinator : Prof. CALAIS
Start date : 2000
Number of patients : 220

Access detailed information on the trial in the private section